Volumetric intravascular ultrasound analysis of paclitaxel-eluting and bare metal stents in acute myocardial infarction: The harmonizing outcomes with revascularization and stents in acute myocardial infarction intravascular ultrasound substudy

Circulation

Volumn 120, Issue 19, 2009, Pages 1875-1882

  Maehara, Akiko ^a   Mintz, Gary S ^a   Lansky, Alexandra J ^a   Witzenbichler, Bernhard ^b   Guagliumi, Giulio ^c   Brodie, Bruce ^d   Kellett, Mirle A ^e   Parise, Helen ^a   Mehran, Roxana ^a   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c OSPEDALI RIUNITI   (Italy)

^d MOSES H CONE MEMORIAL HOSPITAL   (United States)

^e Maine Medical Center   (Australia)

Author keywords

Myocardial infarction; Stents; Ultrasonics

Indexed keywords

PACLITAXEL;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BARE METAL STENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STENT THROMBOSIS; VOLUMETRY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; RECURRENCE; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 72449150228     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.873893     Document Type: Article

References (29)

1. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, Brodie BR, Madonna O, Eijgelshoven M, Lansky AJ, O'Neill WW, Morice MC. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med. 1999;341:1949-1956. (Pubitemid 30010402)
2. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Gua-gliumi G, Stuckey T, Turco M, Carroll JD, Rutherford BD, Lansky AJ. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med. 2002;346:957-966. (Pubitemid 34983245)
3. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. JAMA. 2005;294: 1215-1223.
4. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003; 349:1315-1323.
5. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double-blind, multicenter study of the endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions. Circulation. 2006;114:798-806.
6. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, Varenne O, Cebrian A, Stoll HP, Snead DB, Bode C. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093-1104.
7. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, van der Wieken LR, Tijssen JGP, Rensing BJ, Patterson M. Paclitaxel-eluting versus uncoated stent in primary percutaneous coronary intervention. N Engl J Med. 2006;355:1105-1113.
8. Menichelli M, Parma A, Pucci E, Fiorilli R, De Felice F, Nazzaro M, Giulivi A, Alborino D, Azzellino A, Violini R. Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924-1930.
9. van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, Atsma DE, Bootsma M, Zeppenfeld K, Oemrawsingh PV, van der Wall EE, Schalij MJ. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-months clinical outcome. J Am Coll Cardiol. 2008;51:618-626.
10. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med. 2008;358:2218-2230.
11. Popma JJ, Almonacid A, Lansky AJ. Qualitative and quantitative coronary angiography. In: Topol EJ, ed. Textbook of Interventional Cardiology. Philadelphia, Pa: Saunders; 2008:1071-1093.
12. Mintz GS, Nissen SE, Anderson WD, Rosenfield K, Bailey SR, Siegel RJ, Erbel R, Tuzcu EM, Fitzgerald PJ, Yock PG, Pinto FJ. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS): a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2001;37:1478-1492.
13. De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C, Valgimigli M, Di Lorenzo E, Dirksen MT, Spaulding C, Pittl U,
14. Violini R, Percoco G, Marino P. Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol. 2009;133:213-222.
15. Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med. 2009;360:1946-1959.
16. Weissman NJ, Ellis SG, Grube E, Dawkins KD, Greenberg JD, Mann T, Cannon LA, Cambier PA, Fernandez S, Mintz GS, Mandinov L, Koglin J, Stone GW. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue response: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J. 2007;28:1574-1582.
17. Nakazawa G, Finn AV, Joner M, Ladich E, Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD, Virmani R. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients. Circulation. 2008; 118:1138-1145.
18. Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 2002; 106:1753-1755.
19. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, Park SJ. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004;109:881-886.
20. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, Kim YH, Song JM, Han KH, Kang DH, Cheong SS, Song JK, Kim JJ, Park SW, Park SJ. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414-419.
21. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, Leon MB, Moses JW, Bonneau HN, Fitzgerald PJ. Late incomplete stent malappo-sition after Sirolimus-eluting stent implantation. J Am Coll Cardiol. 2005;46:1002-1005.
22. Cook S, Wenaweser P. Togni M, Billinger M, Morger C, Seiler C, Vogel R, Hess O, Meier B, Windecker S. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426-2434.
23. Hong YJ, Jeong MH, Ahn Y, Sim DS, Chung JW, Cho JS, Yoon NS, Yoon HJ, Moon JY, Kim KH, Park HW, Kim JH, Cho JG, Park JC, Kang JC. Plaque prolapse after stent implantation in patients with acute myocardial infarction. JACC Cardiovasc Imaging. 2008;1: 489-497.
24. Hong MK, Park SW, Lee CW, Kang DH, Song JK, Kim JJ, Park SJ. Long-term outcomes of minor plaque prolapsed within stents documented with intravascular ultrasound. Catheter Cardiovasc Interv. 2000;51: 22-26.
25. Futamatsu H, Sabeté M, Angiolillo DJ, Quevedo PJ, Corros C, Futamatsu KM, Alfonso F, Jiang J, Cervinka P, Antolin RH, Macaya C, Bass TA, Costa MA. Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three dimensional volumetric intravascular ultrasound outcome study. J Am Coll Cardiol. 2006;48: 1139-1145.
26. Suzuki N, Angiolillo DJ, Monteiro C, Shuja S, Futamatsu H, Kawaguchi R, Box LC, Guzman L, Zenni MM, Gilmore PS, Bass TA, Costa MA. Variable histological and ultrasonic characteristics of restenosis after drug-eluting stents. Int J Cardiol. 2008;130:444-448.
27. Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, Liu J, Yang J, Oviedo C, Aoki J, Franklin-Bond T, Dasgupta N, Lansky AJ, Dangas GD, Stone GW, Moses JW, Mehran R, Leon MB. Classification and potential mechanisms of intravascular ultrasound patterns of stent fracture. Am J Cardiol. 2009;103:818-823.
28. Popma JJ. Strut fractures after DES: definitions, frequency, timing, device specificity, and associated clinical events. Transcatheter Cardiovascular Therapeutics. http://www.tctmd.com/txshow.aspx?tid = 2532& id = 73192&trid=2380. Accessed April 8, 2009.
29. Quevedo PJ, Sabaté M, Angiolillo DJ, Costa MA, Alfonso F, Hospital JAG, Antolín RH, Bañuelos C, Goicolea J, Avilés FF, Bass T, Escaned J, Moreno R, Fernández C, Macaya C. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the diabetes and sirolimus-eluting stent (DIABETES) trial. J Am Coll Cardiol. 2006;47:2172-2179.